Glaxo Effort To Verify Gene Data Represents Step For Open Science Forbes GlaxoSmithKline's efforts to fund a 50-person effort with two top universities to verify that the proteins it is picking as targets for drugs are actually involved in the diseases the company hopes to treat are a big example of the Big Pharma dropping ... |
Post a Comment for "Glaxo Effort To Verify Gene Data Represents Step For Open Science - Forbes"